Lumos Diagnostics Holdings Limited Stock: price and insider trades · Australia
1 insider bought €13k of shares over the last 90 days, the latest by DOUG WARD, filed 01 Sept 2026.
Lumos Diagnostics Holdings Limited: what insiders have been doing
Lumos Diagnostics Holdings Limited, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to ASX. 6 insiders have disclosed 11 filings since 28 October 2025.
No insider sold shares on the market over the period. Instead, the filings list 8 purchases totalling €124k, made by 3 insiders. The totals exclude 2 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. One trade stands out by size: a purchase of €36k from Catherine Robson, disclosed on 1 May 2026. Among those who bought: 3 senior executives.
The most recent open-market purchase was published on 1 September 2026, 68 days ago. Filings reach the ASX feed a median of 3 days after the trade. This delay matters because a trade only becomes useful information once it is public.
For context, the typical company on the same exchange (median of 1,603 companies) published 5 filings over the same period, against 11 filings here. The full history, which starts in 2026, counts 8 purchases against no sales.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. Source: insider filings from ASX. Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- +3.1%Entry A$0.10 · Close at T+30 A$0.10
- +0.0%Entry A$0.11 · Close at T+90 A$0.11
- -60.0%Entry A$0.16 · Close 26 Oct 2026 A$0.06
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended June 2026 · cache
- ShareASXASX:2924-03147678-2A1703723
- ShareASXASX:2924-03147677-2A1703722
- ShareASXISIN AU0000157091ASX:2924-03135718-2A1697274
- 202,131 shares@ A$0.1050.020% mcap100.0% of flowShareASXISIN AU0000157091ASX:2924-03130145-2A1694195Canonical exit: 25 Nov 2026 (T+90)
- 4,166,752 sharesShareASXISIN AU0000157091ASX:2924-03114875-2A1686277Canonical exit: 22 Oct 2026 (T+90)
- ▲Executives29,967 AUD0ASX
- ▲Executives31,400 AUD0ASX
- 3,706,331 sharesShareASXASX:2924-03097772-2A1676114Canonical exit: 31 Aug 2026 (T+90)
- ▲Executives59,412 AUD0ASX
- ▲Executives30,000 AUD0ASX
- ▲Executives29,967 AUD0ASX
11 of 11 declarations
About Lumos Diagnostics Holdings Limited
Lumos Diagnostics Holdings Limited is a company focused on the development of rapid diagnostic tests. It is listed on the XASX market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
